Show simple item record

dc.contributor.authorKolu, Päivi
dc.contributor.authorKari, Jaana T
dc.contributor.authorRaitanen, Jani
dc.contributor.authorSievänen, Harri
dc.contributor.authorTokola, Kari
dc.contributor.authorHavas, Eino
dc.contributor.authorPehkonen, Jaakko
dc.contributor.authorTammelin, Tuija H
dc.contributor.authorPahkala, Katja
dc.contributor.authorHutri-Kähönen, Nina
dc.contributor.authorRaitakari, Olli T
dc.contributor.authorVasankari, Tommi
dc.date.accessioned2022-05-03T06:39:43Z
dc.date.available2022-05-03T06:39:43Z
dc.date.issued2022
dc.identifier.citationKolu, P., Kari, J. T., Raitanen, J., Sievänen, H., Tokola, K., Havas, E., Pehkonen, J., Tammelin, T. H., Pahkala, K., Hutri-Kähönen, N., Raitakari, O. T., & Vasankari, T. (2022). Economic burden of low physical activity and high sedentary behaviour in Finland. <i>Journal of Epidemiology and Community Health</i>, <i>76</i>(7), 677-684. <a href="https://doi.org/10.1136/jech-2021-217998" target="_blank">https://doi.org/10.1136/jech-2021-217998</a>
dc.identifier.otherCONVID_118985772
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/80864
dc.description.abstractBackground Low physical activity and high sedentary behaviour are unquestionably relevant for public health while also increasing direct and indirect costs. Methods The authors examined the direct and indirect costs attributable to low physical activity and high sedentary behaviour in Finland in 2017. Costs related to major non-communicable diseases drawn from Finnish registries covered direct costs (outpatient visits, days of inpatient care, medication and institutional eldercare) and indirect costs (sickness-related absences, disability pensions, unemployment benefits, all-cause mortality and losses of income tax revenue). Prevalences of low physical activity and high sedentary behaviour (≥8 hours per 16 waking hours) were based on self-reports among adolescents or accelerometer data among adults and the elderly from three Finnish population studies: FINFIT 2017, Health 2011 and the Cardiovascular Risk in Young Finns Study. Cost calculations used adjusted population attributable fractions (PAF) and regression models. Total annual costs were obtained by multiplying PAF by the total costs of the given disease. Results The total costs of low physical activity in Finland in 2017 came to approximately €3.2 billion, of which direct costs accounted for €683 million and indirect ones for €2.5 billion. Costs attributable to high sedentary behaviour totalled roughly €1.5 billion. Conclusion The findings suggest that low physical activity and high sedentary behaviour levels create substantial societal costs. Therefore, actions intended to increase physical activity and reduce excessive sedentary behaviour throughout life may yield not only better health but also considerable savings to society.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesJournal of Epidemiology and Community Health
dc.rightsCC BY-NC 4.0
dc.titleEconomic burden of low physical activity and high sedentary behaviour in Finland
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202205032528
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.contributor.oppiainePolitiikkarelevantti taloustiede (painoala)fi
dc.contributor.oppiaineTaloustiedefi
dc.contributor.oppiaineEmpirical Microeconomicsfi
dc.contributor.oppiaineBasic or discovery scholarshipfi
dc.contributor.oppiainePolicy-Relevant Economics (focus area)en
dc.contributor.oppiaineEconomicsen
dc.contributor.oppiaineEmpirical Microeconomicsen
dc.contributor.oppiaineBasic or discovery scholarshipen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.description.reviewstatuspeerReviewed
dc.format.pagerange677-684
dc.relation.issn0143-005X
dc.relation.numberinseries7
dc.relation.volume76
dc.type.versionpublishedVersion
dc.rights.copyright© Author(s) (or their employer(s)) 2022. Published by BMJ.
dc.rights.accesslevelopenAccessfi
dc.subject.ysotyökyvyttömyyseläkkeet
dc.subject.ysokuolleisuus
dc.subject.ysotaloudelliset vaikutukset
dc.subject.ysoliikunta
dc.subject.ysoistuminen
dc.subject.ysokustannukset
dc.subject.ysofyysinen aktiivisuus
dc.subject.ysosairastavuus
dc.subject.ysoterveysvaikutukset
dc.subject.ysotartuntataudit
dc.subject.ysotyökyvyttömyys
dc.subject.ysoliikkumattomuus
dc.subject.ysosairauspoissaolot
dc.subject.ysoterveystaloustiede
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p3349
jyx.subject.urihttp://www.yso.fi/onto/yso/p5003
jyx.subject.urihttp://www.yso.fi/onto/yso/p11238
jyx.subject.urihttp://www.yso.fi/onto/yso/p916
jyx.subject.urihttp://www.yso.fi/onto/yso/p13022
jyx.subject.urihttp://www.yso.fi/onto/yso/p7517
jyx.subject.urihttp://www.yso.fi/onto/yso/p23102
jyx.subject.urihttp://www.yso.fi/onto/yso/p3556
jyx.subject.urihttp://www.yso.fi/onto/yso/p15449
jyx.subject.urihttp://www.yso.fi/onto/yso/p1804
jyx.subject.urihttp://www.yso.fi/onto/yso/p10212
jyx.subject.urihttp://www.yso.fi/onto/yso/p24012
jyx.subject.urihttp://www.yso.fi/onto/yso/p24142
jyx.subject.urihttp://www.yso.fi/onto/yso/p17109
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
dc.relation.doi10.1136/jech-2021-217998
jyx.fundinginformationThe Cardiovascular Risk in Young Finns Study has been financially supported by the Academy of Finland, with grants 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (GENDI) and 41071 (SKIDI); the Social Insurance Institution of Finland; Competitive State Research Financing of the expert‑responsibility area of the Kuopio, Tampere and Turku university hospitals (grant agreement X51001); the Juho Vainio Foundation; the Paavo Nurmi Foundation; the Finnish Foundation for Cardiovascular Research; the Finnish Cultural Foundation; the Sigrid Jusélius Foundation; Tampere Tuberculosis Foundation; the Emil Aaltonen Foundation; the Yrjö Jahnsson Foundation; the Signe and Ane Gyllenberg Foundation; Jenny and Antti Wihuri Foundation; the Diabetes Research Foundation of the Finnish Diabetes Association; EU Horizon 2020 (grant agreement 755320, for TAXINOMISIS); the European Research Council (grant agreement 742927, for the MULTIEPIGEN project); and the Tampere University Hospital Support Foundation. The FINFIT 2017 and Health 2011 studies were financed by the Finnish Ministry of Education and Culture, and the Strategic Research Council at the Academy of Finland (320400).


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY-NC 4.0
Except where otherwise noted, this item's license is described as CC BY-NC 4.0